Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | Mink Brook Asset Management LLC10% Owner |  DLHCDLH Holdings Corp.Open-market purchase | BUY | $807 204 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | Mink Brook Asset Management LLC10% Owner | DLHCDLH Holdings Corp. Open-market purchase | BUY | $807 204 sh |
| Sep 18, 2026 traded Sep 17, 2026 |
| 25 | Mink Brook Asset Management LLC10% Owner | DLHCDLH Holdings Corp. Open-market purchase | BUY | $1,241 316 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 25 | Wong-Zaza MelvinaDirector |  KRNYKearny Financial Corp.Open-market purchase | BUY | $15K 1,560 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $155K 1,648 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $148K 1,525 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 |  Pete SessionsRSelf |  ABBVAbbVie Inc.Sale | SELL | $15K – $50K | Sep 18, 2026 traded Sep 14, 2026 |
| 24 | Sanfrey Jeffrey ScottChief Operating Officer |  BLBDBlue Bird CorpOpen-market sale | SELL | $250K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $77K 1,800 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 23 | Sandler Alan B.Chief Development Officer |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $67K 336 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Wetterwald JulienChief Technology Officer |  WLTHWEALTHFRONT CORPOpen-market sale · 10b5-1 plan | SELL | $264K 26.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $4,961 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 18 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $3.01M 107.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO |  WMTWalmart Inc.Open-market sale · 10b5-1 plan | SELL | $646K 6,045 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Furner John R.Director, President & CEO | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $754K 7,080 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Polovin AndrewEVP, Chief Legal Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Wang LingkeDirector, President |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $4.31M 110.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Lin LaurenCLO, CCO and Secretary | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $46K 4,574 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $5,266 27 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 14 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Open-market sale | SELL | $19K 200 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $19K 606 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $853 29 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage |  CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEOpen-market sale · 10b5-1 plan | SELL | $8,760 1,921 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Fukushima RyanCEO, Data | TEMTempus AI, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $2.56M 166.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Nicholas Christopher JamesExecutive Vice President | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,395 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $2.89M 30.0K sh | Sep 18, 2026 traded Sep 18, 2026 |